What Is Keratoconus and How Does It Affect Vision?

Keratoconus is a disease in which the cornea thins and progressively bulges into a cone-like shape. Because the cornea is the eye's clear front surface and does much of the focusing, that change in shape can have a dramatic impact on vision. Intacs® Corneal Implants are an option that may improve vision before a cornea transplant is considered.

What Keratoconus Does to the Eye

The cornea normally holds a rounded, stable curve. In keratoconus, the tissue thins, and the weakened cornea gradually protrudes into a cone. The result is a cornea whose shape no longer focuses light cleanly, which is why vision changes can be significant rather than minor.

How the Changed Shape Affects Vision

The site describes the impact in general terms: the altered corneal shape "can have a dramatic impact on one's vision." It does not list specific symptoms or measurements, so the practical takeaway is that the problem is structural — the eye's focusing surface is being reshaped by the disease — and that vision is the function most directly affected.

Where Intacs® Fits in Treatment

Intacs® Corneal Implants are described as ophthalmic medical devices designed for the reduction or elimination of myopia and astigmatism in patients with keratoconus, so that functional vision may be restored and a corneal transplant can potentially be deferred. In other words, they are positioned as an option to improve vision before a cornea transplant is considered.

Key details from the manufacturer's description:

• Placement: The segments are placed in the periphery of the cornea, outside the central optical zone, at approximately two-thirds depth, inserted surgically through a small radial incision in the corneal stroma.
• Effect: Once in the corneal stroma, the product reshapes and stabilizes the cornea.
• Material and sizing: Made from polymethylmethacrylate (PMMA) and available in different thicknesses.
• Reversibility: The implants are designed to allow removal or replacement.
• Regulatory status: Described as the only FDA-approved intracorneal segments.

What This Means for a Decision

If you or someone you know has keratoconus, the relevant question is whether an option that reshapes and stabilizes the cornea — without removing tissue from the central optical zone — is appropriate before proceeding to transplant. The source presents Intacs® as exactly that earlier-stage option, but it does not discuss candidacy criteria, outcomes, risks, or cost. Those specifics, and whether Intacs® is suitable for a particular eye, are matters to confirm with an eye care professional; the manufacturer's site also provides separate sections for patients and medical professionals for further detail.